MEDIFAST Historical Balance Sheet

MED Stock

USD 26.69 0.76 2.93%

Trend analysis of MEDIFAST INC balance sheet accounts such as Total Current Liabilities of 96.9 M provides information on MEDIFAST INC's total assets, liabilities, and equity, which is the actual value of MEDIFAST INC to its prevalent stockholders. By breaking down trends over time using MEDIFAST INC balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining MEDIFAST INC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MEDIFAST INC is a good buy for the upcoming year.

MEDIFAST INC Inventory

27.77 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

About MEDIFAST Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of MEDIFAST INC at a specified time, usually calculated after every quarter, six months, or one year. MEDIFAST INC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of MEDIFAST INC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which MEDIFAST currently owns. An asset can also be divided into two categories, current and non-current.

MEDIFAST INC Balance Sheet Chart

MEDIFAST INC Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how MEDIFAST INC uses and utilizes its capital. It also shows what exactly a company owns and owes.

At present, MEDIFAST INC's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 49 M, whereas Common Stock Total Equity is forecasted to decline to about 12.3 K.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Other Current Assets Net Working Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of MEDIFAST INC assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MEDIFAST INC books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on MEDIFAST INC balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MEDIFAST INC are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most accounts from MEDIFAST INC's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 49 M, whereas Common Stock Total Equity is forecasted to decline to about 12.3 K.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	32.5M	26.1M	22.0M	23.1M
Total Assets	398.3M	316.2M	309.9M	325.4M

Short Long Term Debt Total Total Assets

MEDIFAST INC balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Other Assets
Total Assets		0.9	0.9	0.95	0.96	0.89	-0.63	0.91	0.81	0.9	0.25	0.79	0.31	0.19	0.2	0.79	0.8	0.66	0.13	0.96	0.88	0.99	0.86	0.19	0.71	0.85
Short Long Term Debt Total	0.9		0.91	0.91	0.82	0.79	-0.46	0.78	0.66	0.82	0.4	0.61	0.25	0.0	-0.03	0.74	0.82	0.64	0.03	0.91	0.83	0.89	0.86	0.0	0.74	0.79
Other Current Liab	0.9	0.91		0.97	0.78	0.73	-0.66	0.82	0.81	0.74	0.37	0.68	0.07	0.04	0.03	0.7	0.84	0.65	-0.13	0.96	0.71	0.92	0.84	0.04	0.74	0.75
Total Current Liabilities	0.95	0.91	0.97		0.84	0.82	-0.63	0.84	0.79	0.82	0.28	0.68	0.08	0.04	0.06	0.77	0.9	0.71	-0.01	1.0	0.79	0.96	0.85	0.04	0.76	0.77
Total Stockholder Equity	0.96	0.82	0.78	0.84		0.85	-0.65	0.92	0.8	0.87	0.22	0.87	0.49	0.3	0.3	0.7	0.63	0.53	0.22	0.84	0.86	0.95	0.77	0.3	0.62	0.86
Property Plant And Equipment Net	0.89	0.79	0.73	0.82	0.85		-0.27	0.74	0.49	0.99	0.09	0.53	0.37	0.33	0.3	0.95	0.74	0.74	0.26	0.86	0.97	0.81	0.84	0.32	0.53	0.77
Net Debt	-0.63	-0.46	-0.66	-0.63	-0.65	-0.27		-0.72	-0.96	-0.28	-0.3	-0.89	-0.03	-0.14	-0.19	-0.1	-0.36	-0.15	0.12	-0.57	-0.25	-0.73	-0.36	-0.14	-0.54	-0.53
Retained Earnings	0.91	0.78	0.82	0.84	0.92	0.74	-0.72		0.84	0.74	0.22	0.87	0.34	0.29	0.33	0.59	0.63	0.55	-0.13	0.83	0.72	0.93	0.69	0.29	0.63	0.71
Cash	0.81	0.66	0.81	0.79	0.8	0.49	-0.96	0.84		0.51	0.35	0.93	0.15	0.12	0.15	0.34	0.53	0.31	-0.06	0.75	0.48	0.87	0.59	0.12	0.6	0.7
Non Current Assets Total	0.9	0.82	0.74	0.82	0.87	0.99	-0.28	0.74	0.51		0.14	0.56	0.45	0.26	0.21	0.93	0.71	0.7	0.29	0.86	0.99	0.82	0.88	0.25	0.52	0.84
Non Currrent Assets Other	0.25	0.4	0.37	0.28	0.22	0.09	-0.3	0.22	0.35	0.14		0.26	0.09	-0.04	-0.22	0.08	0.22	-0.12	0.08	0.26	0.16	0.28	0.33	-0.04	0.25	0.29
Cash And Short Term Investments	0.79	0.61	0.68	0.68	0.87	0.53	-0.89	0.87	0.93	0.56	0.26		0.45	0.24	0.25	0.33	0.35	0.22	0.05	0.65	0.55	0.84	0.56	0.24	0.47	0.76
Net Receivables	0.31	0.25	0.07	0.08	0.49	0.37	-0.03	0.34	0.15	0.45	0.09	0.45		0.09	-0.03	0.26	-0.19	-0.12	0.34	0.1	0.51	0.24	0.43	0.09	-0.2	0.59
Common Stock Total Equity	0.19	0.0	0.04	0.04	0.3	0.33	-0.14	0.29	0.12	0.26	-0.04	0.24	0.09		0.94	0.25	0.02	0.26	0.06	0.07	0.18	0.16	-0.11	1.0	0.2	0.0
Common Stock Shares Outstanding	0.2	-0.03	0.03	0.06	0.3	0.3	-0.19	0.33	0.15	0.21	-0.22	0.25	-0.03	0.94		0.19	0.03	0.29	-0.04	0.08	0.13	0.18	-0.18	0.94	0.21	-0.06
Non Current Liabilities Total	0.79	0.74	0.7	0.77	0.7	0.95	-0.1	0.59	0.34	0.93	0.08	0.33	0.26	0.25	0.19		0.77	0.78	0.23	0.82	0.9	0.71	0.84	0.25	0.45	0.65
Inventory	0.8	0.82	0.84	0.9	0.63	0.74	-0.36	0.63	0.53	0.71	0.22	0.35	-0.19	0.02	0.03	0.77		0.8	0.0	0.91	0.68	0.8	0.71	0.02	0.81	0.5
Other Current Assets	0.66	0.64	0.65	0.71	0.53	0.74	-0.15	0.55	0.31	0.7	-0.12	0.22	-0.12	0.26	0.29	0.78	0.8		-0.05	0.74	0.65	0.62	0.56	0.26	0.63	0.38
Other Stockholder Equity	0.13	0.03	-0.13	-0.01	0.22	0.26	0.12	-0.13	-0.06	0.29	0.08	0.05	0.34	0.06	-0.04	0.23	0.0	-0.05		0.02	0.34	0.06	0.16	0.06	-0.02	0.32
Total Liab	0.96	0.91	0.96	1.0	0.84	0.86	-0.57	0.83	0.75	0.86	0.26	0.65	0.1	0.07	0.08	0.82	0.91	0.74	0.02		0.83	0.95	0.88	0.07	0.74	0.77
Property Plant And Equipment Gross	0.88	0.83	0.71	0.79	0.86	0.97	-0.25	0.72	0.48	0.99	0.16	0.55	0.51	0.18	0.13	0.9	0.68	0.65	0.34	0.83		0.8	0.89	0.18	0.49	0.86
Total Current Assets	0.99	0.89	0.92	0.96	0.95	0.81	-0.73	0.93	0.87	0.82	0.28	0.84	0.24	0.16	0.18	0.71	0.8	0.62	0.06	0.95	0.8		0.81	0.16	0.74	0.81
Short Term Debt	0.86	0.86	0.84	0.85	0.77	0.84	-0.36	0.69	0.59	0.88	0.33	0.56	0.43	-0.11	-0.18	0.84	0.71	0.56	0.16	0.88	0.89	0.81		-0.12	0.41	0.88
Common Stock	0.19	0.0	0.04	0.04	0.3	0.32	-0.14	0.29	0.12	0.25	-0.04	0.24	0.09	1.0	0.94	0.25	0.02	0.26	0.06	0.07	0.18	0.16	-0.12		0.2	0.0
Accounts Payable	0.71	0.74	0.74	0.76	0.62	0.53	-0.54	0.63	0.6	0.52	0.25	0.47	-0.2	0.2	0.21	0.45	0.81	0.63	-0.02	0.74	0.49	0.74	0.41	0.2		0.44
Other Assets	0.85	0.79	0.75	0.77	0.86	0.77	-0.53	0.71	0.7	0.84	0.29	0.76	0.59	0.0	-0.06	0.65	0.5	0.38	0.32	0.77	0.86	0.81	0.88	0.0	0.44

Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	194.7M	276.1M	398.3M	316.2M	309.9M	325.4M
Other Current Liab	49.3M	64.3M	84.4M	69.1M	46.6M	49.0M
Total Current Liabilities	79.4M	111.4M	169.8M	140.9M	92.3M	96.9M
Total Stockholder Equity	104.8M	157.2M	202.5M	155.0M	201.5M	211.6M
Property Plant And Equipment Net	38.8M	38.1M	80.6M	75.6M	67.1M	70.5M
Net Debt	(63.4M)	(152.6M)	(71.6M)	(61.6M)	(72.4M)	(68.8M)
Retained Earnings	168.8M	154.4M	190.3M	139.9M	174.6M	183.4M
Cash	77.0M	163.7M	104.2M	87.7M	94.4M	99.2M
Non Current Assets Total	40.5M	41.8M	91.5M	93.4M	85.9M	90.2M
Non Currrent Assets Other	353K	2.9M	6.5M	12.5M	14.7M	15.4M
Cash And Short Term Investments	92.7M	174.5M	109.5M	87.7M	150.0M	157.5M
Net Receivables	1.0M	1.4M	584K	1.0	8.7M	9.2M
Common Stock Shares Outstanding	12.1M	11.9M	11.8M	11.3M	10.9M	12.2M
Liabilities And Stockholders Equity	194.7M	276.1M	398.3M	316.2M	309.9M	325.4M
Non Current Liabilities Total	10.4M	7.5M	26.0M	20.3M	16.1M	16.9M
Inventory	48.8M	53.4M	180.0M	118.9M	54.6M	27.8M
Other Current Assets	11.3M	5.9M	17.3M	16.2M	10.7M	5.5M
Other Stockholder Equity	(64.0M)	2.8M	12.0M	15.2M	26.6M	27.9M
Total Liab	89.8M	118.8M	195.9M	161.2M	108.4M	113.8M
Property Plant And Equipment Gross	38.8M	38.1M	113.3M	115.6M	114.4M	120.1M
Total Current Assets	154.2M	234.3M	306.9M	222.8M	224.0M	235.2M
Short Term Debt	3.2M	3.7M	6.5M	5.8M	5.9M	6.2M
Accounts Payable	22.6M	35.8M	70.9M	58.7M	39.2M	21.4M
Accumulated Other Comprehensive Income	25K	41K	111K	24K	248K	260.4K
Other Assets	1.7M	14.1M	10.9M	17.8M	20.5M	21.5M
Short Term Investments	15.7M	10.8M	5.4M	(23K)	55.6M	58.4M
Property Plant Equipment	26.0M	27.6M	56.1M	57.2M	65.8M	69.1M
Net Tangible Assets	104.8M	157.2M	202.5M	155.0M	178.3M	125.0M
Retained Earnings Total Equity	168.8M	154.4M	190.3M	139.9M	160.8M	126.9M
Capital Surpluse	0.0	7.8M	12.0M	21.6M	19.4M	10.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:

How To Invest In MEDIFAST

Details

Is MEDIFAST Stock a good investment?

Details

What is MEDIFAST INC's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.

	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	CEOs Directory Screen CEOs from public companies around the world

Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.79)

Dividend Share

3.3

Earnings Share

6.19

Revenue Per Share

82.404

Quarterly Revenue Growth

(0.50)

The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEDIFAST Historical Balance Sheet

MEDIFAST INC Inventory

27.77 Million

About MEDIFAST Balance Sheet Analysis

MEDIFAST INC Balance Sheet Chart

Total Assets

Total Current Liabilities

Other Current Assets

MEDIFAST INC balance sheet Correlations

MEDIFAST INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEDIFAST INC balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for MEDIFAST Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Current Liabilities	+ 0.97	Other Current Liab

Cash	- 0.96	Net Debt
Cash And Short Term Investments	- 0.89	Net Debt
Total Current Assets	- 0.73	Net Debt
Retained Earnings	- 0.72	Net Debt
Net Debt	- 0.66	Other Current Liab
Net Debt	- 0.65	Total Stockholder Equity